Firazyr 30 mg/3 mL single-dose, prefilled syringe Images
Generic Name: icatibant
This medication has been identified as Firazyr 30 mg/3 mL single-dose, prefilled syringe. It is supplied by Takeda Pharmaceutical Company Limited.
Firazyr is used in the treatment of Hereditary Angioedema and belongs to the drug class hereditary angioedema agents. Risk cannot be ruled out during pregnancy. Firazyr 30 mg/3 mL single-dose, prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Firazyr
- Generic Name
- icatibant
- Strength
- 30 mg/3 mL single-dose, prefilled syringe
- Availability
- Prescription only
- Drug Class
- Hereditary angioedema agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceutical Company Limited
- National Drug Code (NDC)
- 54092-0702
See also:
Ruconest
Ruconest is used to treat angioedema attacks in adult and adolescent patients with Hereditary ...
Cinryze
Cinryze (complement C1 esterase inhibitor) is used to prevent attacks of angioedema in people with ...
Orladeyo
Orladeyo (berotralstat) is used to prevent attacks of hereditary angioedema (HAE). Includes ...
Haegarda
Haegarda is an injectable protein replacement therapy that prevents swelling and attacks in ...
Takhzyro
Takhzyro (lanadelumab-flyo) is used to prevent hereditary angioedema (HAE) and reduce symptoms ...
More about Firazyr (icatibant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: hereditary angioedema agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.